ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Duancheng Guo
Matched on ORCID iD 0000-0002-5915-7390; OpenAlex author ID A5013253228. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 6
- Neuro-tumor-immune crosstalk in pancreatic cancer: Mechanisms and therapeutic insights. Co-author DOI 10.1016/j.bbcan.2026.189575↗
- Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. Co-author DOI 10.1186/s13046-025-03563-9↗
- The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer. Co-author DOI 10.1016/j.csbj.2024.09.032↗
- Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway. Co-author DOI 10.3724/abbs.2023286↗
- Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. First author DOI 10.1038/s41419-023-06313-x↗
- Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. Co-author DOI 10.3724/abbs.2023045↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Saimeng Shi · 5 shared papers, 2023–2026 · strength 1.20
- Paper Neuro-tumor-immune crosstalk in pancreatic cancer: Mechanisms and therapeutic insights. DOI 10.1016/j.bbcan.2026.189575↗
- Paper The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pan… DOI 10.1016/j.csbj.2024.09.032↗
- Paper Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. DOI 10.1186/s13046-025-03563-9↗
- Long‐Yun Ye · 5 shared papers, 2023–2025 · strength 1.13
- Paper The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pan… DOI 10.1016/j.csbj.2024.09.032↗
- Paper Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. DOI 10.3724/abbs.2023045↗
- Paper Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. DOI 10.1186/s13046-025-03563-9↗
- Kaizhou Jin · 5 shared papers, 2023–2025 · strength 1.13
- Paper The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pan… DOI 10.1016/j.csbj.2024.09.032↗
- Paper Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. DOI 10.3724/abbs.2023045↗
- Paper Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. DOI 10.1186/s13046-025-03563-9↗
- Weiding Wu · 4 shared papers, 2023–2024 · strength 0.90
- Paper The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pan… DOI 10.1016/j.csbj.2024.09.032↗
- Paper Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. DOI 10.3724/abbs.2023045↗
- Paper Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway. DOI 10.3724/abbs.2023286↗
- Xianjun Yu · 4 shared papers, 2023–2024 · strength 0.90
- Paper The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pan… DOI 10.1016/j.csbj.2024.09.032↗
- Paper Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. DOI 10.3724/abbs.2023045↗
- Paper Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway. DOI 10.3724/abbs.2023286↗
- Qinglin Fei · 3 shared papers, 2023–2025 · strength 0.63
- Paper Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. DOI 10.1186/s13046-025-03563-9↗
- Paper Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway. DOI 10.3724/abbs.2023286↗
- Paper Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. DOI 10.1038/s41419-023-06313-x↗
- Jianguo Jin · 1 shared paper, 2026 · strength 0.32
- Jianhui Yang · 1 shared paper, 2025 · strength 0.23
- Weiding Wu · 1 shared paper, 2025 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.